Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer

被引:46
作者
Cleton-Jansen, AM
Buerger, H
ter Haar, N
Philippo, K
van de Vijver, MJ
Boecker, W
Smit, VTHBM
Cornelisse, CJ
机构
[1] Leiden Univ, Ctr Med, Dept Pathol, NL-2300 RC Leiden, Netherlands
[2] Univ Munster, Inst Pathol, D-4400 Munster, Germany
[3] Dutch Canc Inst, Amsterdam, Netherlands
关键词
D O I
10.1002/gcc.20070
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Loss of heterozygosity (LOH) at the long arm of chromosome 16 is a frequent genetic alteration in breast cancer. It can occur by physical loss of part of or the entire chromosomal arm, resulting in a decrease in copy number or loss followed by mitotic recombination. Comparative genomic hybridization (CGH) demonstrated that well-differentiated breast tumors showed significantly more physical loss of 16q than did poorly differentiated ones and that this difference was already discernable in the preinvasive stage. However, polymorphic markers detected no difference in the frequency of 16q LOH between invasive tumors of different histological grade. Here, by combining data on LOH (n = 52), fluorescence in situ hybridization (n = 18) with chromosome 16-specific probes, and CGH (n = 34), we show a preference in well-differentiated grade I tumors for physical loss of chromosome arm 16q, whereas in poorly differentiated grade III tumors LOH is accompanied by mitotic recombination. This clarifies the discrepancies observed between CGH and LOH for 16q in breast cancer. These different somatic genetic mechanisms may reflect the presence of multiple tumor suppressor genes that are the target of LOH at chromosome arm 16q. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:109 / 116
页数:8
相关论文
共 50 条
  • [1] The genetics and genomics of cancer
    Balmain, A
    Gray, J
    Ponder, B
    [J]. NATURE GENETICS, 2003, 33 (Suppl 3) : 238 - 244
  • [2] BECKER KF, 1994, CANCER RES, V54, P3845
  • [3] PROGNOSTIC-SIGNIFICANCE OF DNA-PLOIDY IN A SERIES OF 690 PRIMARY BREAST-CANCER PATIENTS
    BEERMAN, H
    KLUIN, PM
    HERMANS, J
    VANDEVELDE, CJH
    CORNELISSE, CJ
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1990, 45 (01) : 34 - 39
  • [4] Berx G, 1996, ONCOGENE, V13, P1919
  • [5] E-cadherin is a tumour invasion suppressor gene mutated in human lobular breast cancers
    Berx, G
    CletonJansen, AM
    Nollet, F
    deLeeuw, WJF
    vandeVijver, MJ
    Cornelisse, C
    vanRoy, F
    [J]. EMBO JOURNAL, 1995, 14 (24) : 6107 - 6115
  • [6] Buerger H, 1999, J PATHOL, V189, P521, DOI 10.1002/(SICI)1096-9896(199912)189:4<521::AID-PATH472>3.0.CO
  • [7] 2-B
  • [8] Buerger H, 1999, J PATHOL, V187, P396, DOI 10.1002/(SICI)1096-9896(199903)187:4<396::AID-PATH286>3.0.CO
  • [9] 2-L
  • [10] Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution
    Buerger, H
    Mommers, EC
    Littmann, R
    Simon, R
    Diallo, R
    Poremba, C
    Dockhom-Dworniczak, B
    van Diest, PJ
    Boecker, W
    [J]. JOURNAL OF PATHOLOGY, 2001, 194 (02) : 165 - 170